Drug Type Targeted protein degraders |
Synonyms- |
Target |
Action degraders |
Mechanism CCNE1 degraders(cyclin E1 degraders), CCNE2 degraders(cyclin E2 degraders), CDK2 degraders(Cyclin-dependent kinase 2 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 30 Apr 2025 |